Facebook Pixel Revitalising Cosmetic Standards & Compliance | Bio Spectrum - business - Magzter.comでこの記事を読む

試す - 無料

Revitalising Cosmetic Standards & Compliance

Bio Spectrum

|

October 2025

A huge craze among consumers for cosmeceuticals, by going into marketing and brand appeal, is setting a dangerous precedent.

- Sanjiv Das

Above all, fake cosmetic products have flooded the Indian market, which are easily available online and across street markets. Keeping this in mind and to stop unscrupulous ads, the Ministry of Health and Family Welfare has officially published the Cosmetics (Amendment) Rules, 2025, which introduce a series of changes to the existing Cosmetics Rules, 2020. Experts weigh in on how this Act can be a game-changer in the cosmeceutical sector, provided strict norms are followed. Stacks of cosmetics at medical and departmental stores remind us of the easy availability of the products.

Not realising what best suits the skin, hair etc, without a proper doctor's prescription, consumers are on a buying frenzy, inclined to the marketing and brand appeal rather than thoroughly analysing product details such as ingredients or proper skin type alignment etc.

The cosmeceutical industry is an ever-growing sector backed by consumer awareness, disposable income, a preferential shift towards various products. According to the India Brand Equity Foundation, a trust established by the Department of Commerce, Ministry of Commerce and Industry, Government of India, the cosmeceuticals market generated an estimated revenue of $1.645 billion in 2024 and is projected to reach around $2.27 billion by 2030, growing at a CAGR of approximately 5.4 per cent from 2025 to 2030.

Players in the field are in a rat race to gain consumer preference. Backed by e-commerce and social media platforms, there is no backing out for this growing sector. From bigger pharma giants to smaller players, everyone wants to join the bandwagon. And these are easily available across e-commerce platforms. With products also available on street markets, sometimes having no expiry dates mentioned or a fake one, without proper labelling, is a matter of worry that can lead to serious side effects.

Confiscation of fake cosmetics

Bio Spectrum からのその他のストーリー

Bio Spectrum

Bio Spectrum

Can India's CDMOS Lead the Next Biopharma Wave?

India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).

time to read

8 mins

March 2026

Bio Spectrum

Bio Spectrum

Telangana turns catalyst for innovation

Telangana is at a pivotal moment in its journey as a global life sciences hub.

time to read

6 mins

March 2026

Bio Spectrum

Bio Spectrum

Is AI the New Weapon in the Fight to End TB?

A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).

time to read

2 mins

March 2026

Bio Spectrum

Bio Spectrum

ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India

US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy

Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"

Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer

Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Haleon ropes in Kedar Lele as President for India Subcontinent

Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Centre revises Startup Recognition Framework to strengthen Startup India Action Plan

The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"

In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.

time to read

5 mins

March 2026

Listen

Translate

Share

-
+

Change font size